Out-licensing

ASACOL^®Asacol^® is a mesalazine (5-ASA) based anti-inflammatory drug indicated for the treatment of mild-to-moderate Ulcerative Colitis and Crohn's Disease. We are currently looking for distribution partners in the CEE markets, Latin America and Pan-Asia (excl. Japan & Korea). If Asacol^® fits with your existing gastrointestinal product portfolio, please contact our Business Development & Licensing department.

COLPERMIN^®Colpermin^® contains peppermint oil and is indicated for the symptomatic treatment of bowel spasms and bloating, particularly in irritable bowel syndrome (IBS). Distribution rights for Colpermin^® are available for most countries (North America and Europe: except UK, Ireland, Germany, Austria and Switzerland). If you possess marketing and distribution capabilities in the gastrointestinal field, please contact us.

Asacol^®and Colpermin^® are trade marks or registered trade marks of Tillotts Pharma AG.

Print this page